HIV Databases HIV Databases home HIV Databases home
HIV Sequence Database



Download: ENTIRE SEQUENCE SEQUENCE FRAGMENT start end
Format:  
View NCBI entry		Download GenBank file		Graphics View		Download GFF3 File

LOCUS	    HQ993622		    1377 bp    DNA     linear	VRL 07-NOV-2011
DEFINITION  UNVERIFIED: HIV-1 isolate CP076301584 from Kenya genomic sequence
ACCESSION   HQ993622
VERSION     HQ993622.1 GI:355337471
KEYWORDS    UNVERIFIED.
SOURCE	    Human immunodeficiency virus 1 (HIV-1)
  ORGANISM  Human immunodeficiency virus 1 Viruses; Retro-transcribing viruses;
	    Retroviridae; Orthoretrovirinae; Lentivirus; Primate lentivirus
	    group
REFERENCE   1 (bases 1 to 1377)
            Show all sequences for reference 1
  AUTHORS   Hamers,R.L., Wallis,C.L., Kityo,C., Siwale,M., Mandaliya,K.,
	    Conradie,F., Botes,M.E., Wellington,M., Osibogun,A., Sigaloff,K.C.,
	    Nankya,I., Schuurman,R., Wit,F.W., Stevens,W.S., Van Vugt,M. and de
	    Wit,T.F.
  CONSRTM   for PharmAccess African Studies to Evaluate Resistance (PASER)
  TITLE     HIV-1 drug resistance in antiretroviral-naive individuals in
	    sub-Saharan Africa after rollout of antiretroviral therapy: a
	    multicentre observational study
  JOURNAL   Lancet Infect Dis 11 (10), 750-759 (2011)
  PUBMED    21802367
REFERENCE   2 (bases 1 to 1377)
            Show all sequences for reference 2
  AUTHORS   Hamers,R.L., Wallis,C., Kityo,C., Siwale,M., Conradie,F.,
	    Mandaliya,K., Botes,M., Wellington,M., Osibigun,A.,
	    Sigaloff,K.C.E., Schuurman,R., Stevens,W.S., Van Vugt,M. and Rinke
	    de Wit,T.F.
  CONSRTM   PharmAccess African Studies to Evaluate Resistance (PASER)
  TITLE     Direct Submission
  JOURNAL   Submitted (14-JAN-2011) Amsterdam Institute for Global Health and
	    Development, PharmAccess Foundation, Pietersbergweg 17, Amsterdam,
	    NH 1105BM, The Netherlands
REFERENCE   3
            Show all sequences for reference 3
  AUTHORS   Hamers,R.L., Schuurman,R., Sigaloff,K.C.E., Wallis,C.L., Kityo,C.,
	    Siwale,M., Mandaliya,K., Ive,P., Botes,M.E., Wellington,M.,
	    Osibogun,A., Wit,F.W., Van Vugt,M., Stevens,W.S. and De Wit,T.F.R.
  CONSRTM   PASER
  TITLE     Effect of pretreatment HIV-1 drug resistance on immunological,
	    virological, and drug-resistance outcomes of first-line
	    antiretroviral treatment in sub-Saharan Africa: a multicentre
	    cohort study.
  JOURNAL   Lancet. Infect. Dis.. 12(4); 307-17 (2012)
  PUBMED    22036233
COMMENT     GenBank staff is unable to verify sequence and/or annotation
	    provided by the submitter.
FEATURES             Location/Qualifiers
     source	     1..1377
		     /organism="Human immunodeficiency virus 1"
		     /proviral="Human immunodeficiency virus 1"
		     /mol_type="genomic DNA"
		     /isolate="CP076301584"
		     /host="Homo sapiens"
		     /db_xref="taxon:11676"
		     /country="Kenya"
		     /note="collection date range 2007-2009"
BASE COUNT	531 a	 220 c	  303 g    309 t     14 other
ORIGIN
       1 accagcagag atcttgggga tggggggaga gataacctcc cctccgaagc aggagcagaa 
      61 agacagggaa caggtccaac ccttagtttc cctcaaatca ctctttggca acgacccctt 
     121 gtcacagtaa gaataggaga acatctaaga gaagctctat tagatacagg agcagatgat 
     181 acagtgytag aagatataaa tttgccagga aaatggaagc caaaaatgat agggggaatt 
     241 ggaggtttta tcaaagtaag acagtatgat cagatamyta tagaaatttg tggaaaaaag 
     301 gctataggta cagtrttagt aggacctaca cctgtcaaca taattggaag raatatgttg 
     361 actcagattg gttgyacttt aaattttcca attagtccta ttgagactgt accagtaaaa 
     421 ttaaagccag gaatggatgg cccaagggtt aaacaatggc cattgacaga agaaaaaata 
     481 aaagcattaa cagaaatttg tggagagatg gaaaaggaag gaaaaatttc aaaaattggg 
     541 cctgaaaatc catacaatac tccagtattt gctataaaga aaaaagatag cactaaatgg 
     601 agaaaattag tagattttag agagctcaat aaaagaactc aagacttttg ggaggttcaa 
     661 ttagggatac cacacccagc agggttaaaa aagaaaaaat cagtaacagt actggatgtg 
     721 ggggatgcat atttttcagt tcctttagat gaaaacttta graaatatac tgcattcacc 
     781 ataccyagta taaacaatga gacaccagga atcagatatc agtacaatgt gctcccacag 
     841 ggatggaaag gatcaccagc aatattccag agtagcatga caaaaatctt agagcccttt 
     901 aggacamaaa acccagaaat agttatctat caatacatgg atgacttgta tgtaggatct 
     961 gatttagaaa tagggcagca tagaacaaaa atagargagt taagagaaca tctattgagg 
    1021 tggggattca ccacaccaga caagaaacat cagaaagaac ctccatttct gtggatgggg 
    1081 tatgaactcc atcctgacaa atggacagta cagcctatac wgytgccaga maaagaagac 
    1141 tggactgtca atgatataca gaagttagtg ggaaaattaa aytgggcaag tcagatttac 
    1201 tcagggatta aagtaaggca actgtgtaaa ctccttaggg gagccaaagc attaacagac 
    1261 atagtaccac tgactgaaga agcagaatta gaattggcag agaacaggga aattctaaaa 
    1321 gaaccagtat atggagtata ttatgaccca tcaaaagact taatagctga aatacag
//
last modified: Tue May 31 10:56 2022


Questions or comments? Contact us at seq-info@lanl.gov.

 
Operated by Triad National Security, LLC for the U.S. Department of Energy's National Nuclear Security Administration
© Copyright Triad National Security, LLC. All Rights Reserved | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health